Belfast City Hospital - Articles and news items

NovoSeven resolved 96.5% of bleeds in haemophilia A or B sufferers

Industry news / 6 December 2016 / Niamh Louise Marriott, Digital Editor

NovoSeven, a portable room temperature stable recombinant activated factor VIIa, resolved 96.5% of bleeds demonstrating efficacy with haemophilia…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+